StoneX Group’s Merck MRK Stock Holding History

StoneX Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.5M	Sell	42,565 -357	-0.8%	-$41.8K	0.22%	70
2026 Q1	$5.2M	Sell	42,922 -15,381	-26%	-$1.78M	0.28%	64
2025 Q4	$6.19M	Buy	58,303 +74	+0.1%	+$6.95K	0.27%	71
2025 Q3	$4.93M	Sell	58,229 -2,299	-4%	-$189K	0.22%	94
2025 Q2	$4.84M	Sell	60,528 -2,444	-4%	-$194K	0.24%	83
2025 Q1	$5.69M	Buy	62,972 +3,388	+6%	+$316K	0.31%	69
2024 Q4	$5.96M	Buy	59,584 +20,370	+52%	+$2.1M	0.33%	65
2024 Q3	$4.48M	Buy	39,214 +1,510	+4%	+$179K	0.33%	64
2024 Q2	$4.7M	Buy	37,704 +3,470	+10%	+$447K	0.37%	53
2024 Q1	$4.54M	Buy	34,234 +3,976	+13%	+$490K	0.41%	47
2023 Q4	$3.32M	Buy	30,258 +3,683	+14%	+$382K	0.33%	64
2023 Q3	$2.75M	Buy	26,575 +1,523	+6%	+$164K	0.3%	70
2023 Q2	$2.91M	Sell	25,052 -3,701	-13%	-$420K	0.3%	65
2023 Q1	$3.08M	Buy	28,753 +6,937	+32%	+$749K	0.34%	57
2022 Q4	$2.44M	Sell	21,816 -221	-1%	-$22.6K	0.29%	61
2022 Q3	$1.91M	Buy	22,037 +431	+2%	+$38.5K	0.26%	76
2022 Q2	$1.98M	Sell	21,606 -217	-1%	-$19.2K	0.24%	83
2022 Q1	$1.81M	Buy	21,823 +3,652	+20%	+$288K	0.15%	139
2021 Q4	$1.41M	Buy	18,171 +6,588	+57%	+$525K	0.16%	130
2021 Q3	$878K	Sell	11,583 -327	-3%	-$24.9K	0.13%	175
2021 Q2	$934K	Buy	11,910 +339	+3%	+$25.2K	0.14%	162
2021 Q1	$858K	Buy	11,571 +473	+4%	+$34.9K	0.15%	140
2020 Q4	$873K	Buy	11,098 +1,399	+14%	+$107K	0.19%	110
2020 Q3	$773K	Buy	9,699 +1,150	+13%	+$90.1K	0.25%	101
2020 Q2	$636K	Sell	8,549 -228	-3%	-$17.2K	0.24%	108
2020 Q1	$649K	Sell	8,777 -390	-4%	-$30.7K	0.34%	85
2019 Q4	$801K	Buy	9,167 +884	+11%	+$72.6K	0.33%	93
2019 Q3	$669K	Buy	8,283 +1,262	+18%	+$101K	0.42%	76
2019 Q2	$565K	Buy	7,021 +144	+2%	+$11K	0.36%	89
2019 Q1	$549K	Buy	6,877 +732	+12%	+$54.7K	0.42%	83
2018 Q4	$451K	Buy	6,145 +213	+4%	+$15K	0.44%	82
2018 Q3	$402K	Buy	5,932 +295	+5%	+$18.8K	0.3%	119
2018 Q2	$327K	Sell	5,637 -58	-1%	-$3.27K	0.28%	125
2018 Q1	$296K	Buy	5,695 +91	+2%	+$4.92K	0.28%	142
2017 Q4	$301K	Sell	5,604 -165	-3%	-$9.15K	0.31%	129
2017 Q3	$352K	Sell	5,769 -41,871	-88%	-$2.54M	0.44%	92
2017 Q2	$2.91M	Buy	47,640 +27,115	+132%	+$1.65M	0.91%	10
2017 Q1	$1.15M	Sell	20,525 -279	-1%	-$16.9K	2.58%	10
2016 Q4	$1.17M	Sell	20,804 -2,391	-10%	-$140K	2.04%	11
2016 Q3	$1.38M	Buy	+23,195	New	+$1.36M	3.09%	7

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

StoneX Group's MRK Position: Q2 2026 in Review

StoneX Group reduced its Merck (MRK) stake by 0.83% in Q2 2026, selling an estimated $41.8K and leaving 42,565 shares worth $5.5M. The position accounts for 0.22% of the portfolio, ranked #70.

StoneX Group first reported a position in MRK in Q3 2016 and has held it in 40 quarters since. The position peaked at $6.19M in Q4 2025. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

StoneX Group held 42,565 shares of Merck worth $5.5M as of Q2 2026.
StoneX Group sold 357 Merck shares in Q2 2026, an estimated $41.8K.
Merck made up 0.22% of StoneX Group's portfolio in Q2 2026, its #70 holding.
StoneX Group first reported a position in Merck in Q3 2016 and has held it in 40 quarters since.
StoneX Group's Merck position peaked at $6.19M in Q4 2025.
3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.